Saturday, May 25, 2024
    HomeNationalAstraZeneca Acknowledges Rare Side Effect from Covishield Vaccine

    AstraZeneca Acknowledges Rare Side Effect from Covishield Vaccine

    Related stories

    Bhatti blames demonetisation, GST, and Covid lockdown for economic derailment

    Telangana Deputy CM Bhatti Vikramarka Mallu of the INDIA...

    Bandi lambasts Congress at Vemulawada gathering

    MP Bandi Sanjay Kumar criticized the Congress party during...

    AIM urges government to investigate alleged deaths caused by Covid vaccines

    In light of recent news about AstraZeneca acknowledging Thrombosis...

    In recent news, AstraZeneca, the maker of the Covishield vaccine, has admitted in court documents that its vaccine can cause a rare side effect. The company stated that in very rare cases, the Covishield vaccine may lead to a condition called Thrombosis with Thrombocytopenia Syndrome (TTS). This admission marks a significant change and could result in a substantial legal payout.

    TTS is a rare condition characterized by the formation of blood clots in blood vessels and a low number of blood platelets. It has been observed as an extremely rare adverse effect associated with certain COVID-19 vaccines, particularly those that use adenovirus vectors, like the AstraZeneca vaccine.

    - Advertisement -
    Also read:  Bhatti blames demonetisation, GST, and Covid lockdown for economic derailment

    Dr. Jagadish J Hiremath, a public health expert, explained that while TTS is exceedingly rare, certain factors like age, gender (more common in younger women), and possibly genetic factors might predispose individuals to this condition. Healthcare providers are urged to monitor for symptoms of TTS, especially in individuals at higher risk, to manage and treat the condition promptly.

    Symptoms of TTS include severe headache, blurred vision, chest pain, leg swelling, persistent abdominal pain, and shortness of breath, typically appearing within a few weeks after vaccination. Early detection and treatment are crucial for recovery, emphasizing the importance of vigilance from both healthcare providers and patients.

    - Advertisement -
    Also read:  Dr. Krishna Ella Receives Highest Medal of Honor from Johns Hopkins Bloomberg School for Outstanding Contributions to Public Health

    This acknowledgment by AstraZeneca could impact public trust in vaccines, as it raises questions about vaccine safety. It may also lead to enhanced safety monitoring and regulatory oversight for vaccines in the future.

    - Advertisement -
    Rajesh M
    Rajesh M
    Latest News from Hyderabad, Telangana, India & World!

    Follow us


    Contribute News

    You can contribute an article to Telangana Tribune by dropping a mail at

    Latest stories


    Please enter your comment!
    Please enter your name here